Balasa Dinverno & Foltz LLC Zoetis Inc. Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 2,052 shares of ZTS stock, worth $337,759. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,052
Previous 2,005
2.34%
Holding current value
$337,759
Previous $345,000
11.88%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding ZTS
# of Institutions
1,957Shares Held
410MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$6.79 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.06 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.26 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.64 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.53 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $77.1B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...